Search

Your search keyword '"Carrasquillo, Minerva M"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Carrasquillo, Minerva M" Remove constraint Author: "Carrasquillo, Minerva M" Database Unpaywall Remove constraint Database: Unpaywall
136 results on '"Carrasquillo, Minerva M"'

Search Results

1. Large- Scale Deep Proteomic Analysis in Alzheimer's Disease Brain Regions Across Race and Ethnicity

3. Plasma biomarkers of Alzheimer’s disease in a biracial, community‐based sample

4. Gliovascular molecular alterations in Alzheimer’s disease: a cross‐tissue, cross‐species study

5. Blood co‐expression network analysis identifies molecular pathways involved in cognitive resilience

7. Network‐based pipeline guides knowledge‐driven prioritization and validation of therapeutic target discovery for Alzheimer’s disease

8. Identification of genes and blood co‐expression networks associated with cerebrovascular neuroimaging phenotypes

9. Targeted plasma eQTL and pQTL to identify potential novel biomarkers for Alzheimer’s Disease in African Americans

10. DNA methylation clustered by predicted chromatin state reveals distinct association patterns with neuropathologic and biochemical measures in the AD brain

11. Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy

12. LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry

13. Association of Plasma Biomarkers of Alzheimer Disease With Cognition and Medical Comorbidities in a Biracial Cohort

14. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifiesLRRC4C, LHX5-AS1and nominates ancestry-specific lociPTPRK,GRB14, andKIAA0825as novel risk loci for Alzheimer’s disease: the Alzheimer’s Disease Genetics Consortium

16. Single Cell Approaches Reveal Perturbed Brain Vascular Molecules in Alzheimer’s Disease

17. Integrative single‐nucleus RNAseq analysis identifies cell‐type‐specific expression perturbations in progressive supranuclear palsy

19. Association of DNA methylation from the temporal cortex and cerebellum with AD‐related neuropathology and biochemistry

20. Polygenic risk score analysis identifies deleterious protein-coding variants in novel immune pathway genes ATP8B4, FCGR1A, and LILRB1 that associate with Alzheimer’s disease.

21. Polygenic risk score analysis identifies deleterious protein-coding variants in novel immune pathway genesATP8B4, FCGR1A, andLILRB1that associate with Alzheimer’s disease

22. APOE ε4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease

23. Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's Disease related proteins

24. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease

25. Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans

26. Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions

27. Single Nuclei Transcriptome Reveals Perturbed Brain Vascular Molecules in Alzheimer's Disease

29. Plasma transcript profiling identifies significant differentially expressed genes and expression of quantitative trait loci in African Americans

30. Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease

31. Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy

32. Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease

33. Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies

34. Latent trait modeling of tau neuropathology in progressive supranuclear palsy

37. Apolipoprotein E

38. Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease

39. Conserved Architecture of Brain Transcriptome Changes between Alzheimer’s Disease and Progressive Supranuclear Palsy in Pathologically Affected and Unaffected Regions

40. Plasma Biomarkers of Alzheimer’s Disease in African Americans

41. Transcript Levels in Plasma Contribute Substantial Predictive Value as Potential Alzheimer's Disease Biomarkers in African Americans

42. Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5

43. Investigating gene expression changes underlying selective hippocampal vulnerability in Alzheimer’s disease using a translational neuropathology approach

45. Identification of novel Alzheimer’s disease genes co-expressed with TREM2

46. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy

47. Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains

48. Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer's disease

49. Impact of Variant-level Batch Effects on Identification of Genetic Risk Factors in Large Sequencing Studies

50. Deciphering cellular transcriptional alterations in Alzheimer’s disease brains

Catalog

Books, media, physical & digital resources